Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 12, 2025 3:20 PM EST